XERS Competitors & Alternatives
Compare Xeris Pharmaceuticals Inc with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
XERS
Main Stock$7.40
Tradestie Score
67
Market Cap
$1.29B
P/E Ratio
102.9
Revenue Growth
0.4%
Analyst Upside
+52.5%
Top Competitors
46 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BCRX
BioCryst Pharmaceuticals Inc
|
$10.00
|
$1.55B | - | 59 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$17.00
|
$1.49B | - | 63 | Compare |
|
AVDL
Avadel Pharmaceuticals plc Ordinary Share
|
$21.64
|
$1.46B | - | 62 | Compare |
|
EVO
Evotec SE American Depositary Shares
|
$2.69
|
$1.34B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$6.19
|
$1.29B | - | 56 | Compare |
|
AMPH
Amphastar Pharmaceuticals, Inc.
|
$21.02
|
$1.25B | 12.1 | 58 | Compare |
|
DVAX
Dynavax Technologies Corporation
|
$15.50
|
$1.21B | - | 55 | Compare |
|
PCRX
Pacira BioSciences, Inc. Common Stock
|
$23.96
|
$1.14B | 180.8 | 64 | Compare |
|
COLL
Collegium Pharmaceutical, Inc. Common Stock
|
$35.58
|
$1.11B | 16.7 | 61 | Compare |
|
CRON
Cronos Group Inc. Common Share
|
$2.71
|
$1.02B | - | 55 | Compare |
More XERS Analysis
Data updated: Jun 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
46 stocks in this industry